Joe Scalzo: Yes, let — I’ll start and I’ll turn it over to Geoff. Obviously, he’s got some fresh eyes on the matter. But look, it’s — the press of the event and the actual number of users, there’s a pretty big gap right now. So it’s still very early innings on these weight loss drugs because they tend to be coastal in their use right now based on everything that we’ve seen. You’re seeing a lot of pickup on the press. So this is still very early innings. So we actually don’t see this as a threat but we see it as an opportunity and I’ll provide some color commentary. First of all, typically people that are using these drugs have a significant amount of weight to lose, call it, 20-plus per ounce, 20, 25 pounds of weight to lose, right?
That is not the epicenter of the buyer Atkins anymore and hasn’t been for a number of years. The number of our buyers who are actively using the Atkins program to lose a significant amount of weight is kind of mid-single digits as a percent. So it’s not a threat from a volume standpoint but we think actually an opportunity from a marketing standpoint. So that — look, the drugs are driving renewed interest in weight management and that’s always a good thing for your business because the challenge as you know from your experience with the brand, the challenge is getting people actually to take interest to action when it comes to how they look and how they feel. And so these drugs, I think, are starting to renew interest in consumers to change behavior.
So news is a good thing, not unlike [indiscernible] was for us, right? It wasn’t us but we were able to kind of get on that wave or ride that wave for over 3 years. So as I think there’s 2 elements of opportunity for us and Geoff and the team are already on them. The first is people come to pharmacies to get the drug, that’s where our brand is. There is an opportunity to tap into that. And as you would imagine, major retailers are really interested in having that conversation. The second, the drugs and this is the nuance of this, the drugs suppress appetite. So you’re eating fewer calories and the calories you actually eat have to be more nutritious. So there is an opportunity for our brand. And I think you’re seeing the weight wellness other brands do exactly the same thing, right?
That you end up having to help people eat more healthy, i.e., you need to be on a program as you’re using these things. Otherwise, you’re going to do damage to your body and getting — not getting enough nutrition to it. So our strategy, as we’re starting to think through it, our strategy is actually to market Atkins is a perfect complement to people thinking about using the drugs. And we have a rich pedigree as a nutrition philosophy to help people think about that and then use our relationships in the pharmacy aisle to market to it. So we’re actually pretty optimistic. We like this as a tailwind. We think it’s going to be a pretty good wave. I don’t think it’s going to have the fattish nature of keto [ph], I think it will build, it will build for a sustained period of time.
And I think there’s a real opportunity for the brand to take advantage of it. And I’ll turn it over to Geoff for any thoughts he’s got.
